What is Seaport Therapeutics 's stock-based comp?

Seaport Therapeutics (SPTX) reported stock-based comp of $2.57M in Q1 2026.

What does stock-based comp mean?

Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.

Seaport Therapeutics SPTX Stock-Based Comp

Stock-Based Comp at other companies

MYR GroupMYRG

$3.39M+45.1%

Macy'sM

$14M+7.7%

Moelis & CompanyMC

$72.21M-16.3%

BalchemBCPC

$5.36M+40.6%

Alignment HealthcareALHC

$14.02M-18.4%

Sabra HealthcareSBRA

$3.1M+14.3%

Other financials

Income statement

See full

Operating income-$27.5M-70.2%

Net income-$25.4M-93.6%

EPS (diluted)-$10.34-83.0%

Balance sheet

See full

Cash & equivalents$52.9M—

Total debt$5.3M—

Total equity-$115.6M-220%

Total assets$227.7M—

Cash flow

See full

Operating cash flow-$20.2M+0.2%

CapEx--100%

Free cash flow-$20.2M+0.4%

Valuation

See full

Market cap$972.65M—

Enterprise value$925.08M—

Returns & leverage

See full

Debt / equity-0×—

Current ratio13.2×—

Where this comes from

Reported directly by Seaport Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:AllocatedShareBasedCompensationExpense.

The official record: Seaport Therapeutics ’s 10-Q, filed June 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Seaport Therapeutics 's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Seaport Therapeutics 's stock-based comp?: Seaport Therapeutics (SPTX) reported stock-based comp of $2.57M in Q1 2026.
What does stock-based comp mean?: Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.